Mia's Feed
Medical News & Research

Emerging Role of Fat Particles in Treating Metabolic Brain Disorders

Emerging Role of Fat Particles in Treating Metabolic Brain Disorders

Share this article

New research uncovers how fats serve as vital energy sources in neurons, offering promising new strategies for treating metabolic and neurodegenerative brain disorders.

2 min read

Recent research from the University of Queensland has challenged the traditional view that neuronal activity in the brain relies solely on sugars for energy. A groundbreaking study led by Dr. Merja Joensuu, published in Nature Metabolism, reveals that fats also play a crucial role in powering neurons responsible for thought, movement, and other brain functions.

The study highlights that neurons utilize small fat molecules, known as saturated free fatty acids, produced by the enzyme DDHD2, to generate energy necessary for neuronal communication. This discovery provides new insights into the brain's metabolic processes and opens up potential avenues for treating neurodegenerative and metabolic brain disorders.

Researchers focused on hereditary spastic paraplegia 54 (HSP54), a condition linked to the dysfunction of the DDHD2 gene, which disrupts the brain’s fat balance and impairs neural function. They found that in neurons with defective DDHD2, supplementing with activated fatty acids restored energy production and normal neuronal activity, even when sugar-based approaches failed.

This paradigm shift suggests that healthy neurons produce saturated fatty acids internally to fuel their activity. In disorders like HSP54, replenishing these fats can potentially repair neuronal energy pathways, offering hope for previously untreatable neurodegenerative diseases.

Further studies demonstrated that fatty acid supplements could be effective in animal models, reversing energy deficits. This finding points toward the potential development of clinical therapies based on fatty acid supplementation for brain diseases characterized by metabolic dysfunction.

The research team plans to advance this work by assessing the safety and therapeutic efficacy of fatty acid treatments in preclinical trials, aiming to explore their application in various metabolic brain disorders, including Alzheimer’s and other neurodegenerative conditions.

This discovery not only broadens our understanding of brain energy metabolism but also proposes a novel approach to tackling complex neurological diseases through metabolic intervention.

Source: https://medicalxpress.com/news/2025-09-fat-particles-key-metabolic-brain.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Urban Environments and Their Impact on Asthma Development

Urban environments significantly increase the risk of developing asthma due to air pollution, limited green spaces, and urban infrastructure, highlighting the importance of sustainable city planning for respiratory health.

Limitations of Current Biomarkers in Assessing Post-Pregnancy Heart Failure Risk

New research questions the effectiveness of traditional biomarkers like NT-proBNP for predicting heart failure in women after complicated pregnancies, emphasizing the need for new screening methods.

Isolated REM Sleep Behavior Disorder as an Early Predictor for Parkinson's Disease and Dementia

New research from the University of Montreal reveals biomarkers in isolated REM sleep behavior disorder that can predict the development of Parkinson's disease and dementia years before symptoms appear, paving the way for early personalized interventions.

Increasing Staff Levels in Aged Care: Does More Staffing Improve Care Quality?

While increased staffing levels in aged care homes meet targets, recent research questions whether it truly improves care quality. A nuanced approach focusing on workforce skills and support is crucial for better outcomes.